Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer

Michael Fisch, Ju-Whei Lee, Matthias Weiss, +8

Journal of Clinical Oncology

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

G Lemma, Ju-Whei Lee, Seena C. Aisner, +4

Journal of Clinical Oncology

Cross-Cultural Variations in Probability Judgment Accuracy: Beyond General Knowledge Overconfidence?

J. Frank Yates, Ju-Whei Lee, Hiromi Shinotsuka, +2

Organizational Behavior and Human Decision Processes

CultureCognitive ScienceProbability Judgment AccuracyJudgement AggregationBehavioral Decision Making +11

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, +5

Journal of Clinical Oncology

Beliefs about Overconfidence, Including Its Cross-National Variation

J. Frank Yates, Ju-Whei Lee, Hiromi Shinotsuka

Organizational Behavior and Human Decision Processes

Social BiasCross-national VariationBiasPolitical BehaviorCognitive Bias Mitigation +1

Good probabilistic forecasters: The ‘consumer's’ perspective

J. Frank Yates, Paul C. Price, Ju-Whei Lee, +1

International Journal of Forecasting

Business ForecastingEconomic ForecastingProbabilistic ForecastingPredictive AnalyticsManagement +5

Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008

Chezi Ganzel, Judith Manola, Dan Douer, +10

Journal of Clinical Oncology

Mixed-phenotype Acute LeukemiaPathologyMyeloid NeoplasiaHematological MalignancyAcute Myeloid Leukemia +15

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups

Marlise R. Luskin, Ju-Whei Lee, Hugo F. Fernández, +13

Blood

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Simon Mantha, Debra A. Goldman, Sean M. Devlin, +20

Blood

A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

Anne M. Traynor, Ju-Whei Lee, Gerald K. Bayer, +6

Investigational New Drugs

Second Line TreatmentOncologyPhase Ii TrialMetronomic TherapyBronchial Neoplasm +6